导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -17.23% | 959/1050 |
| 近一周 | -2.69% | 867/1104 |
| 近一月 | -5.60% | 825/1103 |
| 近一季 | 0.03% | 298/1092 |
| 近半年 | -18.73% | 979/1070 |
| 近一年 | -24.54% | 950/1018 |
| 近两年 | 4.50% | 866/926 |
| 近三年 | -17.46% | 762/834 |
| 成立以来 | 268.60% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-4.53% 784/1070 |
-16.11% 1036/1101 |
- - |
- - |
| 2025 | 4.38% 893/1065 |
-1.61% 885/1014 |
4.63% 319/1038 |
11.98% 807/1050 |
-9.45% 865/1065 |
| 2024 | 10.23% 283/1011 |
1.49% 234/960 |
-0.81% 363/983 |
15.37% 212/991 |
-5.09% 673/1011 |
| 2023 | -16.74% 591/952 |
-0.40% 645/880 |
-2.55% 340/895 |
-1.85% 152/915 |
-12.60% 905/952 |
| 2022 | -3.50% 30/867 |
-1.17% 8/773 |
2.25% 659/806 |
-2.68% 35/845 |
-1.87% 531/867 |
| 2021 | 27.46% 90/740 |
7.84% 20/580 |
4.59% 473/659 |
4.18% 141/704 |
8.47% 113/740 |
| 2020 | 107.00% 19/554 |
5.25% 72/419 |
31.54% 106/466 |
31.52% 4/517 |
13.68% 234/554 |
| 2019 | 54.05% 122/410 |
30.81% 334/1149 |
-2.78% 570/1231 |
11.58% 86/390 |
8.55% 217/410 |
| 2018 | -22.69% 109/349 |
- - |
- - |
- - |
-9.23% 238/1080 |
| 2017 | 26.34% 57/285 |
- - |
- - |
- - |
- - |
| 2016 | -2.08% 34/205 |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票C | 0.8165 | 61.04% |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商医药健康产业股票 | 2.6450 | 53.78% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 嘉实医疗保健股票 | 2.6190 | 42.34% |
| 前海开源公共卫生股票C | 0.4647 | 42.24% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 广发医药精选股票C | 1.3103 | 40.86% |
| 交银医药创新股票C | 3.0948 | 37.26% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 工银战略转型股票A VS. 东吴新产业精选股票A(580008) |